Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05972330 · ClinicalTrials.gov registry record · NA
Efficacy of VRx MyBiotics Oral Lozenges
A NA study of Oral Microbiome Health, sponsored by Viome.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT05972330 is a NA study of Oral Microbiome Health that has completed, run by Viome. The registered enrollment target is 34 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05972330, a NA study of Oral Microbiome Health, has completed, sponsored by Viome.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the efficacy of Viome's VRx MyBiotics Oral Lozenges at improving the oral microbiome.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT VRx MyBiotics Oral Lozenges
Study Locations (1)
Washington
- Viome Life Sciences - Bothell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2023-06-26 |
| Est. Completion | 2024-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05972330
The ClinicalTrials.gov registry entry for NCT05972330 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Viome, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oral Microbiome Health appearing as the primary indexed condition, and to 1 intervention - of which VRx MyBiotics Oral Lozenges is the first listed.
NCT05972330 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT05972330 about?
NCT05972330 is a clinical study titled "Efficacy of VRx MyBiotics Oral Lozenges". This study will test the efficacy of Viome's VRx MyBiotics Oral Lozenges at improving the oral microbiome.
What is the current status of trial NCT05972330?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2023-06-26. Estimated completion is 2024-01-26.
What conditions does trial NCT05972330 study?
This clinical trial studies the following conditions: Oral Microbiome Health.
What interventions are being tested in trial NCT05972330?
The interventions under investigation include: VRx MyBiotics Oral Lozenges (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05972330?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05972330 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.